In last trading session, Can-Fite BioPharma Ltd. (NYSE:CANF) saw 1,979,090 shares changing hands with its beta currently measuring 1.09. Company’s recent per share price level of $1.7601 trading at -$0.23 or -11.75% at recent trade assigns it a market valuation of $24.11 Million. That current price of CANF’s stock is at a discount of -181.23% from its 52-week high price of $4.95 and is indicating a premium of 38.64% from its 52-week low price of $1.08. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.67 Million shares which gives us an average trading volume of 1.2 Million if we extend that period to 3-months.

Can-Fite BioPharma Ltd. (NYSE:CANF) trade information

In the face of being in the red today for losing -11.05%, in the last five days CANF remained trading in the green while hitting it’s week-highest on Monday, Jun 29 when the stock touched $2.45-2 price level, adding 27.35% to its value on the day. Can-Fite BioPharma Ltd.’s shares saw a change of -46.06% in year-to-date performance and have moved -5.32% in past 5-day. Can-Fite BioPharma Ltd. (NYSE:CANF) showed a performance of -7.29% in past 30-days. Number of shares sold short was 166.49 Million shares which calculate 138.74 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $6 to the stock, which implies a rise of 240.89% to its current value. Analysts have been projecting $5 as a low price target for the stock while placing it at a high target of $7. It follows that stock’s current price would jump +297.7% in reaching the projected high whereas dropping to the targeted low would mean a loss of 184.07% for stock’s current value.

Can-Fite BioPharma Ltd. (CANF) estimates and forecasts

Statistics highlight that Can-Fite BioPharma Ltd. is scoring comparatively lower than the scores of other players of the relevant industry. The company lessened -35.9% of value to its shares in past 6 months, showing an annual growth rate of -61.52% while that of industry is 10.4. Apart from that, the company came raising its revenue forecast for fiscal year 2020. The company is estimating its revenue growth to increase by 74% in the current quarter and calculating 64.4% increase in the next quarter. This year revenue growth is estimated to drop -53.2% from the last financial year’s standing.

2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $250Million for the same. And 2 analysts are in estimates of company making revenue of $250Million in the next quarter that will end in September 01, 2020. Company posted $389Million and $1.15 Million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to drop by -35.7% while estimating it to be -78.3% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 56.4% while estimates for its earnings growth in next 5 years are of 0%